ConvaTec Group PLC Director/PDMR Shareholding (2512F)
October 25 2018 - 12:42PM
UK Regulatory
TIDMCTEC
RNS Number : 2512F
ConvaTec Group PLC
25 October 2018
25 October 2018
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 24 October 2018, the Company's Interim Chief Executive
Officer and a PDMR, purchased 75,000 Shares at GBP1.536789 per
share. Mr Anderson's resulting shareholding is 149,475 Shares.
The attached notification, made in accordance with the
requirements of the EU Market Abuse Regulation, gives further
detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Rick Anderson
2 Reason for the notification
a) Position/Status Interim Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
instrument, type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction 1. Purchase of Shares on 24 October 2018
c) Price(s) and volume(s) Price(s) Volume(s)
GBP1.536789 75,000
d) Aggregated information
- Aggregated volume 75,000
- Price GBP115,259.18
e) Date of the transaction 24 October 2018
f) Place of the transaction London Stock Exchange, Main Market (XLON)
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141
435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion devices. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFVDIDLEFIT
(END) Dow Jones Newswires
October 25, 2018 13:42 ET (17:42 GMT)
Convatec (LSE:CTEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Convatec (LSE:CTEC)
Historical Stock Chart
From Apr 2023 to Apr 2024